Covid-19 Antibody Treatments Need More Work: Johns Hopkins

The video discusses the role of antibodies and T cells in COVID-19 immunity, comparing natural infection and vaccine-induced antibodies. It highlights the ongoing research to understand the immune response and the importance of phase three trials in determining vaccine efficacy and safety. The video also addresses the rapid development of promising vaccine candidates and the challenges in ensuring broad protection and large-scale production.

How do researchers assess the immune response generated by different vaccine candidates?

What factors contribute to the safety and efficacy of vaccine candidates?